newsfilter
← Latest News
GlobeNewswire·

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

HANOVER, Md., June 17, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) (the "Company"), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced